Thierry Mauvernay – President and Delegate of the Board, Debiopharm, Switzerland

Thierry Mauvernay, president and delegate of the board of Debiopharm, discusses the Swiss Group’s development over its 38 years of history, its unique business strategy, and how new trends such as personalized medicine and digitalization are being embraced moving forward.  
Our goal is not to become much bigger, but smarter and more intelligent. We have to be even more focused and agile
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report